Clinical Trial Update: Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of MBS2320 in healthy subjects and rheumatoid arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MBS2320

Snippet

Sponsor: Modern Biosciences Ltd | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED